University of Miami/UHealth
Miami, United States
Name: Michael (Young Taek) Oh
Affiliation: University of Miami
Title: Associate scientist
[Education]
- M.S. & Ph.D. in Health Sciences and Technology (03/2011-02/2018)
Sungkyunkwan University, Korea
- B.S. in Bio-technology (03/2006-02/2010)
Yonsei University, Korea
[Work Experience]
- Associate scientist (09/2022-Present)
University of Miami/UHealth, USA
- Postdoctoral research scientist (09/2018-08/2022)
Columbia University Medical Center, USA
- Technical research personnel and Postdoctoral researcher (03/2015-08/2018)
National Cancer Center, Korea
[Representative Publications]
- Garofano L*, Migliozzi S*, Oh YT*, D’Angelo F, Najac RD, Ko A, Frangaj B, Caruso FP, Yu K, Yuan J, Zhao W, Stefano ALD, Bielle F, Jiang T, Sims P, Suvà ML, Tang F, Su X, Ceccarelli M, Sanson M, Lasorella A**, Iavarone A**. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities. Nature Cancer. (2021)
- Yin J*, Kim SS*, Choi E*, Oh YT*, Lin W, Kim TH, Sa JK, Hong JH, Park SH, Kwon HJ, Jin X, You Y, Kim JH, Kim H, Son J, Lee J, Nam DH, Choi KS, Shi B, Gwak HS, Yoo H, Iavarone A**, Kim JH**, Park JB**. ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages. Nature Communication. (2020)
- Yin J*, Oh YT*, Kim JY*, Kim SS, Choi E, Kim TH, Hong JH, Chang N, Cho HJ, Sa JK, Kim JC, Kwon HJ, Park S, Lin W, Nakano I, Gwak HS, Yoo H, Lee SH, Lee J, Kim JH, Kim SY, Nam DH**, Park MJ**, Park JB**. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling. Cancer Research. (2017)